Literature DB >> 11413168

A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation.

L Coscoy1, D Ganem.   

Abstract

Kaposi's sarcoma-associated (KS-associated) herpesvirus (KSHV) is a B-lymphotropic agent linked to AIDS-related lymphoproliferative disorders and KS. We and others have earlier identified two viral genes, K3 and K5, that encode endoplasmic reticulum proteins that downregulate surface MHC-I chains by enhancing their endocytosis. Here we have examined the ability of these proteins to influence the disposition of other host surface proteins implicated in immune recognition and activation. We report that K5, but not K3, expression in BJAB cells dramatically reduces ICAM-1 and B7-2 surface expression; B7-1 expression is unaffected. This K5-induced reduction can be reversed by coexpression of a dominant negative mutant of dynamin, indicating that the loss of ICAM and B7-2 surface expression is due to their enhanced endocytosis. This downregulation is functionally significant, because K5-transfected B cells show substantial impairment in their ability to induce T cell activation. K5 is thus the first example of a viral modulator of immunological synapse formation and T cell costimulation. We propose that its expression reduces T cell responses to KSHV-infected B cells early in infection, thereby diminishing antiviral cytokine release and the production of stimulatory signals for CTL generation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11413168      PMCID: PMC200195          DOI: 10.1172/JCI12432

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  57 in total

1.  Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins.

Authors:  S Ishido; C Wang; B S Lee; G B Cohen; J U Jung
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 2.  Viral subversion of the immune system.

Authors:  D Tortorella; B E Gewurz; M H Furman; D J Schust; H L Ploegh
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 3.  Mechanisms of viral interference with MHC class I antigen processing and presentation.

Authors:  J W Yewdell; J R Bennink
Journal:  Annu Rev Cell Dev Biol       Date:  1999       Impact factor: 13.827

Review 4.  Lymphocyte responses and cytokines.

Authors:  W E Paul; R A Seder
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

5.  In vivo activation of naive T cells by antigen-presenting B cells.

Authors:  S C Morris; A Lees; F D Finkelman
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

6.  Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line.

Authors:  M Azuma; M Cayabyab; D Buck; J H Phillips; L L Lanier
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

7.  Parameters of tolerance induction by antigen targeted to B lymphocytes.

Authors:  E E Eynon; D C Parker
Journal:  J Immunol       Date:  1993-09-15       Impact factor: 5.422

8.  Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen.

Authors:  D J Lenschow; A I Sperling; M P Cooke; G Freeman; L Rhee; D C Decker; G Gray; L M Nadler; C C Goodnow; J A Bluestone
Journal:  J Immunol       Date:  1994-09-01       Impact factor: 5.422

9.  Costimulation of T cell receptor/CD3-mediated activation of resting human CD4+ T cells by leukocyte function-associated antigen-1 ligand intercellular cell adhesion molecule-1 involves prolonged inositol phospholipid hydrolysis and sustained increase of intracellular Ca2+ levels.

Authors:  G A Van Seventer; E Bonvini; H Yamada; A Conti; S Stringfellow; C H June; S Shaw
Journal:  J Immunol       Date:  1992-12-15       Impact factor: 5.422

10.  Effects of mutant rat dynamin on endocytosis.

Authors:  J S Herskovits; C C Burgess; R A Obar; R B Vallee
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

View more
  116 in total

1.  Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101-dependent degradation.

Authors:  Eric W Hewitt; Lidia Duncan; Dina Mufti; John Baker; Philip G Stevenson; Paul J Lehner
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

Review 2.  Lessons from viral manipulation of protein disposal pathways.

Authors:  Margo H Furman; Hidde L Ploegh
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 3.  The MHC class I antigen presentation pathway: strategies for viral immune evasion.

Authors:  Eric W Hewitt
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

4.  Cytotoxic T lymphocytes form an antigen-independent ring junction.

Authors:  Kristina Somersalo; Nadja Anikeeva; Tasha N Sims; V Kaye Thomas; Roland K Strong; Thomas Spies; Tatiana Lebedeva; Yuri Sykulev; Michael L Dustin
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

5.  Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins.

Authors:  Eric Bartee; Mandana Mansouri; Bianca T Hovey Nerenberg; Kristine Gouveia; Klaus Früh
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

6.  Analysis of 4.3 kilobases of divergent locus B of macaque retroperitoneal fibromatosis-associated herpesvirus reveals a close similarity in gene sequence and genome organization to Kaposi's sarcoma-associated herpesvirus.

Authors:  Timothy M Rose; Jonathan T Ryan; Emily R Schultz; Brian W Raden; Che-Chung Tsai
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

7.  The intertransmembrane region of Kaposi's sarcoma-associated herpesvirus modulator of immune recognition 2 contributes to B7-2 downregulation.

Authors:  Mizuho Kajikawa; Pai-Chi Li; Eiji Goto; Naoyuki Miyashita; Masami Aoki-Kawasumi; Mari Mito-Yoshida; Mika Ikegaya; Yuji Sugita; Satoshi Ishido
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

Review 8.  Immune evasion by Kaposi's sarcoma-associated herpesvirus.

Authors:  Hye-Ra Lee; Stacy Lee; Preet M Chaudhary; Parkash Gill; Jae U Jung
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

9.  Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

Authors:  Shahram Salek-Ardakani; Ramon Arens; Rachel Flynn; Alessandro Sette; Stephen P Schoenberger; Michael Croft
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

10.  Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus.

Authors:  Mandana Mansouri; Patrick P Rose; Ashlee V Moses; Klaus Früh
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.